The Society of Hospital Pharmacists of Australia (SHPA) has hosted a successful, celebratory and all-virtual 2020 SHPA Virtual Congress.
The innovative project will integrate genomics, electronic healthcare data and AI technologies to address antimicrobial resistance in the healthcare system.
Interim analysis of Moderna's Phase 3 study of mRNA-1273 finds that the COVID-19 vaccine candidate has an efficacy of 94.5% and remains stable at -20°C for up to six months.
A tech partnership means that carers can now access a tool to help identify, monitor and reduce pain in dementia aged-care residents.
One of the world's most common infections will cost Australia more than $1 billion a year within the next decade if nothing is done to stop the rise of antibiotic-resistant bacteria.
Pregnant women who contract COVID-19 may be at higher risk of blood clotting, especially those who become severely ill with the virus, says Associate Professor Sanjaya Senanayake of the Australian National University.
Reported to have endured the largest institutional outbreak of COVID-19 in healthcare workers in Australia, the RMH's multidimensional response has been examined.
GE Healthcare and GenesisCare have partnered to tackle the globe's greatest health burdens: cancer and cardiovascular disease.
Macquarie University researchers have unveiled a strategy that models who should be vaccinated first.
Pfizer and BioNTech have issued a press release, announcing that their vaccine candidate is more than 90% effective in preventing COVID-19.
The secret pathway used by some aggressive breast cancers to avoid detection has been uncovered by researchers at Macquarie University.
Child and adolescent exposure to poisoning while at school is relatively common and appears to be increasing, according to research from the University of Sydney.
The Australian Government has secured two more potential coronavirus vaccines for Australia.
The active compound in magic mushrooms — psilocybin — has been found to produce large, rapid and sustained improvements in patients with treatment-resistant major depressive disorder.
With the use of medication being the most common healthcare intervention, the challenge of upholding safety has never been more important.